The Use of Genomics to Drive Kidney Disease Drug Discovery and Development.

Abstract excerpt

As opposed to diseases such as cancer, autoimmune disease, and diabetes, identifying drugs to treat CKD has proven significantly more challenging. Over the past 2 decades, new potential therapeutic targets have been identified as genetically altered proteins involved in rare monogenetic kidney diseases. Other possible target genes have been implicated through common genetic polymorphisms associated with CKD in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Development
• Share to Drug Discovery
• Share to Genetic Predisposition to Disease